Fagotti, Anna
Fagotti, Anna
ROMA - Dipartimento di Scienze della vita e sanità pubblica
A commentary on the discrepancy between blood and tumour BRCA testing: An open question
2022 De Paolis, Elisa; Marchetti, Claudia; Concolino, Paola; Scambia, Giovanni; Urbani, Andrea; Fagotti, Anna; Minucci, Angelo
A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer
2022 Chiusolo, Patrizia; Marchetti, Claudia; Rossi, Monica; Minnella, Gessica; Salutari, Vanda; Distefano, Mariagrazia; Giammarco, Sabrina; Metafuni, Elisabetta; Minucci, Angelo; Frioni, Filippo; Gasbarrino, Cristiana; Colangelo, Maria; Orteschi, Daniela; Fagotti, Anna; Lorusso, Domenica; Pagano, Livio; De Stefano, Valerio; Scambia, Giovanni; Sica, Simona
A Laparoscopic Adjusted Model Able to Predict the Risk of Intraoperative Capsule Rupture in Early-stage Ovarian Cancer: Laparoscopic Ovarian Cancer Spillage Score (LOChneSS Study)
2022 Ghirardi, V.; De Felice, F.; Rosati, A.; Ergasti, R.; Gueli Alletti, S.; Mascilini, F.; Scambia, G.; Fagotti, A.
ASO Author Reflections: Laparoscopic Ovarian Transposition for Locally Advanced Cervical Cancer-Tailoring the Treatment with the Standardization of a Surgical Procedure
2022 Bizzarri, Nicolò; Loverro, Matteo; Angeles, Martina A; Pedone Anchora, Luigi; Fagotti, Anna; Fanfani, Francesco; Ferrandina, Gabriella; Scambia, Giovanni; Querleu, Denis
BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score
2022 Ergasti, R.; Marchetti, C.; Tudisco, R.; Iervolino, A.; Naldini, A.; Oliva, R.; Inzani, F.; Scambia, G.; Fagotti, A.
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: A performance evaluation
2022 De Paolis, E.; Perrucci, A.; Marchetti, C.; Pietragalla, A.; Scambia, G.; Urbani, A.; Fagotti, A.; Minucci, A.
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital
2022 Bizzarri, N.; Nero, C.; Sillano, F.; Ciccarone, F.; D'oria, M.; Cesario, A.; Fragomeni, S. M.; Testa, A. C.; Fanfani, F.; Ferrandina, G.; Lorusso, D.; Fagotti, A.; Scambia, G.
Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team
2022 Federico, A.; Fragomeni, S. M.; Tagliaferri, L.; Guajardo Rios, L. S.; Lancellotta, V.; Gentileschi, S.; Corrado, G.; Gui, B.; Colloca, G.; Rufini, V.; Fagotti, A.; Scambia, G.; Garganese, G.
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer
2022 Nero, C.; Boldrini, L.; Lenkowicz, J.; Giudice, M. T.; Piermattei, A.; Inzani, F.; Pasciuto, T.; Minucci, A.; Fagotti, A.; Zannoni, G.; Valentini, V.; Scambia, G.
Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer
2022 Moruzzi, M. C.; Bolomini, G.; Esposito, R.; Mascilini, F.; Ciccarone, F.; Quagliozzi, L.; Giudice, M. T.; Beneduce, G.; Ficarelli, S.; Moroni, R.; Scambia, G.; Fagotti, A.; Testa, A. C.; Moro, F.
Different Surgical Approaches for Early-Stage Ovarian Cancer Staging. A Large Monocentric Experience
2022 Cianci, S.; Capozzi, V. A.; Rosati, A.; Rumolo, V.; Corrado, G.; Uccella, S.; Gueli Alletti, S.; Ricco, M.; Fagotti, A.; Scambia, G.; Cosentino, F.
Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?
2022 Ghirardi, V.; De Felice, F.; D'Indinosante, M.; Bernardini, F.; Giudice, M. T.; Fagotti, A.; Scambia, G.
Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients
2022 Buttarelli, M.; Ciucci, A.; Palluzzi, F.; Raspaglio, G.; Marchetti, C.; Perrone, E.; Minucci, A.; Giaco, L.; Fagotti, A.; Scambia, G.; Gallo, D.
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections
2022 Di Giambenedetto, S.; Borghetti, A.; Quagliozzi, L.; Gallucci, V.; Lombardi, F.; Ciccullo, A.; Fagotti, A.; Tamburrini, E.; Scambia, G.
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer
2022 Nero, C.; Romito, I.; Spadola, S.; Romito, A.; Turco, L. C.; Cosentino, F.; De Ninno, M.; Catena, U.; De Cicco Nardone, A.; Moroni, R.; Zannoni, G.; Fagotti, A.; Scambia, G.
Isolated tumour cells in a sentinel lymph node of apparent early-stage ovarian cancer: Ultrastaging of all other 27 lymph nodes
2022 Uccella, S.; Bosco, M.; Fagotti, A.; Garzon, S.; Zorzato, P. C.; Tinelli, R.; Biletta, E.; Porcari, I.; Liscia, D.; Scambia, G.; Franchi, M.
Laparoscopic Ovarian Transposition with Extraperitonealization of the Infundibulopelvic Ligament for Cervical Cancer in Ten Steps
2022 Bizzarri, N.; Loverro, M.; Angeles, M. A.; Pedone Anchora, L.; Fagotti, A.; Fanfani, F.; Ferrandina, G.; Scambia, G.; Querleu, D.
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance
2022 Palluzzi, E.; Marchetti, C.; Cappuccio, S.; Avesani, G.; Macchia, G.; Gambacorta, M. A.; Cocciolillo, F.; Scambia, G.; Fagotti, A.
MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis
2022 Musacchio, L.; Valsecchi, A. A.; Salutari, V.; Valabrega, G.; Camarda, F.; Tuninetti, V.; Giannone, G.; Bartoletti, M.; Marchetti, C.; Pignata, S.; Fagotti, A.; Scambia, G.; Di Maio, M.; Lorusso, D.
Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study
2022 Bernardini, F.; Ferrandina, G.; Ricci, C.; Fagotti, A.; Fanfani, F.; Cavaliere, A. F.; Gui, B.; Scambia, G.; De Vincenzo, R.
Data di pubblicazione | Titolo | Autore(i) | File |
---|---|---|---|
1-gen-2022 | A commentary on the discrepancy between blood and tumour BRCA testing: An open question | De Paolis, Elisa; Marchetti, Claudia; Concolino, Paola; Scambia, Giovanni; Urbani, Andrea; Fagotti, Anna; Minucci, Angelo | |
1-gen-2022 | A common pattern of somatic mutations in t-MDS/AML of patients treated with PARP inhibitors for metastatic ovarian cancer | Chiusolo, Patrizia; Marchetti, Claudia; Rossi, Monica; Minnella, Gessica; Salutari, Vanda; Distefano, Mariagrazia; Giammarco, Sabrina; Metafuni, Elisabetta; Minucci, Angelo; Frioni, Filippo; Gasbarrino, Cristiana; Colangelo, Maria; Orteschi, Daniela; Fagotti, Anna; Lorusso, Domenica; Pagano, Livio; De Stefano, Valerio; Scambia, Giovanni; Sica, Simona | |
1-gen-2022 | A Laparoscopic Adjusted Model Able to Predict the Risk of Intraoperative Capsule Rupture in Early-stage Ovarian Cancer: Laparoscopic Ovarian Cancer Spillage Score (LOChneSS Study) | Ghirardi, V.; De Felice, F.; Rosati, A.; Ergasti, R.; Gueli Alletti, S.; Mascilini, F.; Scambia, G.; Fagotti, A. | |
1-gen-2022 | ASO Author Reflections: Laparoscopic Ovarian Transposition for Locally Advanced Cervical Cancer-Tailoring the Treatment with the Standardization of a Surgical Procedure | Bizzarri, Nicolò; Loverro, Matteo; Angeles, Martina A; Pedone Anchora, Luigi; Fagotti, Anna; Fanfani, Francesco; Ferrandina, Gabriella; Scambia, Giovanni; Querleu, Denis | |
1-gen-2022 | BRCA status and platinum sensitivity in advanced ovarian cancer according to Chemotherapy Response Score | Ergasti, R.; Marchetti, C.; Tudisco, R.; Iervolino, A.; Naldini, A.; Oliva, R.; Inzani, F.; Scambia, G.; Fagotti, A. | |
1-gen-2022 | BRCA testing on buccal swab to improve access to healthcare and cancer prevention: A performance evaluation | De Paolis, E.; Perrucci, A.; Marchetti, C.; Pietragalla, A.; Scambia, G.; Urbani, A.; Fagotti, A.; Minucci, A. | |
1-gen-2022 | Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital | Bizzarri, N.; Nero, C.; Sillano, F.; Ciccarone, F.; D'oria, M.; Cesario, A.; Fragomeni, S. M.; Testa, A. C.; Fanfani, F.; Ferrandina, G.; Lorusso, D.; Fagotti, A.; Scambia, G. | |
1-gen-2022 | Clinical impact of SARS-CoV-2 infection among patients with vulvar cancer: the Gemelli Vul.Can multidisciplinary team | Federico, A.; Fragomeni, S. M.; Tagliaferri, L.; Guajardo Rios, L. S.; Lancellotta, V.; Gentileschi, S.; Corrado, G.; Gui, B.; Colloca, G.; Rufini, V.; Fagotti, A.; Scambia, G.; Garganese, G. | |
1-gen-2022 | Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer | Nero, C.; Boldrini, L.; Lenkowicz, J.; Giudice, M. T.; Piermattei, A.; Inzani, F.; Pasciuto, T.; Minucci, A.; Fagotti, A.; Zannoni, G.; Valentini, V.; Scambia, G. | |
1-gen-2022 | Diagnostic performance of ultrasound in assessing the extension of disease in advanced ovarian cancer | Moruzzi, M. C.; Bolomini, G.; Esposito, R.; Mascilini, F.; Ciccarone, F.; Quagliozzi, L.; Giudice, M. T.; Beneduce, G.; Ficarelli, S.; Moroni, R.; Scambia, G.; Fagotti, A.; Testa, A. C.; Moro, F. | |
1-gen-2022 | Different Surgical Approaches for Early-Stage Ovarian Cancer Staging. A Large Monocentric Experience | Cianci, S.; Capozzi, V. A.; Rosati, A.; Rumolo, V.; Corrado, G.; Uccella, S.; Gueli Alletti, S.; Ricco, M.; Fagotti, A.; Scambia, G.; Cosentino, F. | |
1-gen-2022 | Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference? | Ghirardi, V.; De Felice, F.; D'Indinosante, M.; Bernardini, F.; Giudice, M. T.; Fagotti, A.; Scambia, G. | |
1-gen-2022 | Identification of a novel gene signature predicting response to first-line chemotherapy in BRCA wild-type high-grade serous ovarian cancer patients | Buttarelli, M.; Ciucci, A.; Palluzzi, F.; Raspaglio, G.; Marchetti, C.; Perrone, E.; Minucci, A.; Giaco, L.; Fagotti, A.; Scambia, G.; Gallo, D. | |
1-gen-2022 | Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections | Di Giambenedetto, S.; Borghetti, A.; Quagliozzi, L.; Gallucci, V.; Lombardi, F.; Ciccullo, A.; Fagotti, A.; Tamburrini, E.; Scambia, G. | |
1-gen-2022 | Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer | Nero, C.; Romito, I.; Spadola, S.; Romito, A.; Turco, L. C.; Cosentino, F.; De Ninno, M.; Catena, U.; De Cicco Nardone, A.; Moroni, R.; Zannoni, G.; Fagotti, A.; Scambia, G. | |
1-gen-2022 | Isolated tumour cells in a sentinel lymph node of apparent early-stage ovarian cancer: Ultrastaging of all other 27 lymph nodes | Uccella, S.; Bosco, M.; Fagotti, A.; Garzon, S.; Zorzato, P. C.; Tinelli, R.; Biletta, E.; Porcari, I.; Liscia, D.; Scambia, G.; Franchi, M. | |
1-gen-2022 | Laparoscopic Ovarian Transposition with Extraperitonealization of the Infundibulopelvic Ligament for Cervical Cancer in Ten Steps | Bizzarri, N.; Loverro, M.; Angeles, M. A.; Pedone Anchora, L.; Fagotti, A.; Fanfani, F.; Ferrandina, G.; Scambia, G.; Querleu, D. | |
1-gen-2022 | Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance | Palluzzi, E.; Marchetti, C.; Cappuccio, S.; Avesani, G.; Macchia, G.; Gambacorta, M. A.; Cocciolillo, F.; Scambia, G.; Fagotti, A. | |
1-gen-2022 | MEK inhibitor as single agent in low grade serous ovarian and peritoneal cancer: a systematic review and meta-analysis | Musacchio, L.; Valsecchi, A. A.; Salutari, V.; Valabrega, G.; Camarda, F.; Tuninetti, V.; Giannone, G.; Bartoletti, M.; Marchetti, C.; Pignata, S.; Fagotti, A.; Scambia, G.; Di Maio, M.; Lorusso, D. | |
1-gen-2022 | Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study | Bernardini, F.; Ferrandina, G.; Ricci, C.; Fagotti, A.; Fanfani, F.; Cavaliere, A. F.; Gui, B.; Scambia, G.; De Vincenzo, R. |